The Association of Healthcare Internal Auditors (AHIA) 38th Annual Conference, “Harmonizing the Complexities of Healthcare Internal Auditing,” took place September 15-18, 2019, in Nashville, TN. The event offered healthcare professionals growth and development opportunities on a variety of emerging topics. A host of PYA thought leaders were among those on the agenda to discuss industry changes.
PYA Principal Tynan Kugler and Consulting Manager Susan Thomas presented “Auditing Healthcare Focus Arrangements for Regulatory Compliance: Physicians, Management Services, Post-Discharge Care, Ambulance Services, and Specialty Care.” In their presentation, they:
- Described what constitutes a focus arrangement for healthcare organizations.
- Explained the implications of Stark Law and Anti-Kickback violations, along with Corporate Integrity Agreement focus arrangement requirements.
- Discussed essential focus arrangement procedures to facilitate regulatory compliance.
- Provided an example design of an audit plan approach for focus arrangements.
View the presentation below.
PYA Tampa Office Managing Principal Angie Caldwell and Consulting Senior Manager Sarah Bowman addressed “The Opioid Epidemic: An Important Auditor Update” in their presentation. They:
- Provided an overview of the scope of the opioid crisis, emerging trends in opioid abuse, and recent regulatory activity.
- Analyzed key internal control risk areas to prevent drug diversion.
- Reviewed specific examples of monitoring for fraud and abuse related to the opioid epidemic.
View the presentation below.
PYA Principal Barry Mathis presented “The IT Analysis Paralysis,” in which attendees:
- Received a compressive review of the many IT frameworks that can be used to develop effective internal audit programs.
- Learned the differences between commercial, federal, and industry frameworks.
- Received tips, tools, and techniques for creating an effective framework based on risk assessment and identified risks.
View the presentation below.
PYA Consulting Senior Manager Sarah Bowman also presented “The Current Regulatory Environment and Auditing Urine Drug Testing.” Attendees:
- Learned the history of urine drug test (UDT) billing changes.
- Understood current requirements of UDT coding and documentation.
- Learned common compliance issues.
- Became familiar with best practice recommendations.
View the presentation below.
If you would like more information about focus arrangements, monitoring for fraud and abuse related to the opioid crisis, or the current regulatory and auditing environment for UDT, or would like assistance with any matter involving healthcare audit or compliance, contact one of our PYA executives below at (800) 270-9629.
